RxDoctor Payments DataLook up a doctor →

Thom Dahle, MD

Interventional Cardiology · Saint Cloud, MNNPI 1760458673

Payments from drug & device makers

$2,228,013in general payments, 2019–2025

Across 1,259 payments — averaging $1769.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1.2M
  • Abiomed$385K
  • Boston Scientific$239K
  • Medtronic$208K
  • Abbott$55K
  • Cardiovascular Systems Inc.$42K
  • plus $91K from 19 others
$30,930in research payments, 2019–2025

Across 11 payments — averaging $2811.84 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$19K
  • Arrow International, Inc.$11K
  • Abiomed$220

What the payments were for

  • Consulting fees$323,92330%
  • Speaking & faculty fees$635,64960%
  • Travel & lodging$74,6037%
  • Food & beverage$30,0523%
  • Gifts$450%
  • Entertainment$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,228,013 in reported general payments places this provider in the 95th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$135,531
Medicare patients
457
Services billed
977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$24,122
Metoprolol Succinate87$1,303
Atorvastatin Calcium33$432
ClopidogrelClopidogrel Bisulfate18$401
Lisinopril29$371
Losartan Potassium16$204
Spironolactone24$197
Warfarin Sodium15$190
Amlodipine Besylate31$162
Furosemide12$35

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Saint Cloud

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →